Represented PharmaCyte Biotech, Inc., a clinical-stage international biotechnology company providing cell and gene therapy solutions, in an “at the market” banking agreement with Chardan Capital Markets, LLC of up to $50 million.
-
-
Vice Chair, Loeb & Loeb LLP; Co-Chair, Capital Markets and Corporate -
Assistant Deputy Chair, Capital Markets and Corporate